LYBALVI Trademark

Trademark Overview


On Thursday, June 10, 2021, a trademark application was filed for LYBALVI with the United States Patent and Trademark Office. The USPTO has given the LYBALVI trademark a serial number of 90765843. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, May 26, 2023. This trademark is owned by Alkermes Pharma Ireland Limited. The LYBALVI trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs

Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms

Support services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program

Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes
lybalvi

General Information


Serial Number90765843
Word MarkLYBALVI
Filing DateThursday, June 10, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, May 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Description of MarkThe mark consists of the word "LYBALVI" in blue below a curved two-paneled ribbon design, the bottom portion of the ribbon being blue and the top portion being a mixture of gold and brown, commonly referred to as metallic copper.
Goods and ServicesProviding information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs
Indication of Colors claimedThe color(s) blue and metallic copper is/are claimed as a feature of the mark.
Goods and ServicesLogistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms
Goods and ServicesSupport services for health care providers and their patients in the nature of providing case management services, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program; providing case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement of medication in the nature of conducting benefits verification with payers to facilitate prescription fulfilment and coordinating with non-commercial pharmacy to facilitate prescription fulfilment for patients eligible for patient assistance program
Goods and ServicesProviding educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code035
First Use Anywhere DateFriday, January 21, 2022
First Use In Commerce DateWednesday, February 23, 2022

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code036
First Use Anywhere DateFriday, January 21, 2022
First Use In Commerce DateWednesday, February 23, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code044
First Use Anywhere DateFriday, January 21, 2022
First Use In Commerce DateWednesday, February 23, 2022

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code045
First Use Anywhere DateFriday, January 21, 2022
First Use In Commerce DateWednesday, February 23, 2022

Trademark Owner History


Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin 4
IE

Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin 4
IE

Trademark Events


Event DateEvent Description
Saturday, May 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 26, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, May 26, 2023SOU EXTENSION 1 GRANTED
Friday, May 19, 2023SOU EXTENSION 1 FILED
Friday, May 19, 2023USE AMENDMENT FILED
Thursday, May 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 19, 2023TEAS EXTENSION RECEIVED
Friday, May 19, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 17, 2022NEW NOA TO ISSUE
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 26, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, April 26, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 26, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, April 26, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, April 15, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 29, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 14, 2022EXAMINER'S AMENDMENT ENTERED
Monday, March 14, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 14, 2022EXAMINERS AMENDMENT E-MAILED
Monday, March 14, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Wednesday, September 1, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 14, 2021NEW APPLICATION ENTERED